Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data
about
Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reportsChallenges and Opportunities for Exploring Patient-Level DataStatins for primary cardiovascular prevention in the elderlyOpenTrials: towards a collaborative open database of all available information on all clinical trialsPublished and unpublished evidence in coverage decision-making for pharmaceuticals in Europe: existing approaches and way forward.Quality and quantity of information in summary basis of decision documents issued by health CanadaAssessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document AnalysisReporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic ReviewClinical research data sharing: what an open science world means for researchers involved in evidence synthesisIncreasing value and reducing waste: addressing inaccessible researchMoving forward from rhBMP-2: open science and data sharingInformation on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports.Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional studyHow to get all trials reported: audit, better data, and individual accountability.Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications.Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reportsImpact of inclusion of industry trial results registries as an information source for systematic reviews.Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability.Understanding adverse drug reactions in package leaflets - an exploratory survey among health care professionals.Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: cohort study using a primary care database.Against vaccine assay secrecy.Publication and non-publication of drug trial results: a 10-year cohort of trials in Norwegian general practice.Consolidated Standards of Reporting Trials (CONSORT): considerations for neuropsychological research.Celebrating 20 years of evidence from the Cochrane Collaboration: what has been the impact of systematic reviews on nephrology?Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect.QUALITY OF SAMPLE SIZE ESTIMATION IN TRIALS OF MEDICAL DEVICES: HIGH-RISK DEVICES FOR NEUROLOGICAL CONDITIONS AS EXAMPLE.Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trialsCommentary on Berlin et al.Identifying problematic drugs based on the characteristics of their targetsWhy clinical trial outcomes fail to translate into benefits for patients.An analysis of redactions in Canada's Common Drug Review Clinical Review Reports and how they relate to the patients' voice.Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients.[Benefit assessment of drugs].The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authorsFactors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review
P2860
Q26773320-1B79A876-615B-4C0D-897D-087F6D692CD7Q26778595-2034689F-6E7B-4C85-A492-E84291B55C44Q26783401-BE25DA82-9FA3-4DE2-8C3B-C546E3456D96Q26834199-B7C04FED-A9CA-41F7-BE70-10ABB2C1A5BFQ27303825-952F341A-A9B5-41AB-B9E5-221AC68B0196Q28541228-1BFC16C0-74E9-4F38-B5EF-64797E9E0001Q28553552-4E96B095-1939-4E8D-835B-37B52F23D32AQ28554247-2F42D16D-2086-4B9B-8163-C8F1CA4DD2B7Q28595531-7B620BC3-B122-40A5-B6E4-119C8D0533E2Q28611347-F54ABF0F-E966-4283-A78E-B0A537883B26Q28660290-183F159E-DB6C-4A07-9DCA-E51546FF011AQ30487681-96847B7E-62FC-47A4-97A5-6255C5BE727BQ30583430-647C24F1-388F-43F3-BCF3-0BE790F82BDEQ30932208-A08AD75E-6784-4324-8AE5-F738A3B5D981Q33710440-E83C5F61-A1F2-46B6-B9AE-B7E525CED0BCQ34264254-9E99BEF3-BC3B-4994-A89B-4FEF0B67ED64Q35151458-ED5B8AC2-5698-408A-BE0C-709171522DE0Q35347819-519F27F1-93AF-40BA-B8DA-E878F64161A4Q35837043-9B835423-8B9D-401F-8598-04DD04B1DE86Q35871895-70A9CDA5-48B8-42DA-B7B1-7303D2FC7193Q35887486-2BD7C3C0-6579-4D9E-9E9A-FCBDAF3D9CE0Q36819100-5E568743-CCCE-4065-8ED1-F07A6D153BE7Q38207150-3951FE20-0C98-49BD-908A-07AC2250EFB0Q38228729-B92F3442-CC9C-4D67-81DD-25F0E40DE985Q38614034-AA697047-3765-49F8-BEF8-BAE7A89D14C1Q38787245-C49CD6FE-433E-4735-869F-E3DE288260D9Q38814635-560B4A44-09A6-41C0-8586-E0BB68F29EA3Q39026466-7560C214-3C7E-4FD2-9B21-F5BF47BB9A95Q40520056-E6A9D41E-44DD-44E2-ABC4-E51099A2920DQ42316662-F3B253D5-F23C-4AD4-AA66-4502343A9C13Q42357776-88ECC24F-2D15-465C-82A8-441BD5C25680Q47140896-0DC0837A-9592-41F9-A23E-CAB8F47A3D76Q53643814-53F65524-0EFB-4852-89CE-FC6E9A4EA38CQ57170319-23A3C1D6-322A-49F6-BAFB-340C2BBF62F3Q58797089-339794F2-6ED2-432A-A3E2-24453770F4E5
P2860
Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Completeness of reporting of p ...... s with publicly available data
@ast
Completeness of reporting of p ...... s with publicly available data
@en
Completeness of reporting of p ...... s with publicly available data
@nl
type
label
Completeness of reporting of p ...... s with publicly available data
@ast
Completeness of reporting of p ...... s with publicly available data
@en
Completeness of reporting of p ...... s with publicly available data
@nl
prefLabel
Completeness of reporting of p ...... s with publicly available data
@ast
Completeness of reporting of p ...... s with publicly available data
@en
Completeness of reporting of p ...... s with publicly available data
@nl
P2093
P2860
P3181
P1433
P1476
Completeness of reporting of p ...... s with publicly available data
@en
P2093
Beate Wieseler
Marloes Kamphuis
Michaela F Kerekes
Natalia Wolfram
Natalie McGauran
Petra Kohlepp
Ulrich Grouven
Volker Vervölgyi
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1001526
P407
P577
2013-10-01T00:00:00Z